Jan. 30 (Bloomberg) -- Daiichi Sankyo Co.'s drug Injectafer, which the company proposed selling for iron deficiency anemia, may pose ``serious safety concerns,’' U.S. regulators said.
Jan. 30 (Bloomberg) -- Daiichi Sankyo Co.'s drug Injectafer, which the company proposed selling for iron deficiency anemia, may pose ``serious safety concerns,’' U.S. regulators said.
